Diane C. Young's Insider Trades & SAST Disclosures
Diane C. Young's most recent trade in Celldex Therapeutics Inc. was a trade of 72,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Diane C. Young.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 72,000 | 72,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 15,000 | 0 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.71 per share. | 11 Jun 2024 | 15,000 | 17,115 (0%) | 0% | 2.7 | 40,650 | Common Stock |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.26 per share. | 07 Jun 2024 | 45,000 | 2,115 (0%) | 0% | 35.3 | 1,586,844 | Common Stock |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 80,000 | 80,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.71 per share. | 17 Aug 2022 | 45,000 | 47,115 (0%) | 0% | 2.7 | 121,950 | Common Stock |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 45,000 | 15,000 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 19,000 | 48,400 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.30 per share. | 17 Aug 2022 | 19,000 | 2,115 (0%) | 0% | 37.3 | 708,715 | Common Stock |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 17 Aug 2022 | 19,000 | 21,115 (0%) | 0% | 10.4 | 197,220 | Common Stock |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 76,000 | 76,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.94 per share. | 12 Nov 2021 | 4,600 | 2,115 (0%) | 0% | 42.9 | 197,529 | Common Stock |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 4,600 | 67,400 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 12 Nov 2021 | 4,600 | 6,715 (0%) | 0% | 10.4 | 47,748 | Common Stock |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 72,000 | 72,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 72,000 | 72,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Diane C. Young | SVP, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.73 per share. | 11 Jun 2020 | 2,115 | 2,115 | - | 4.7 | 10,004 | Common stock, par value $0.001 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges